Not exact matches
What federal
oversight should embryonic stem
cell research have that other forms of biomedical
research, including those involving human subjects, do not already have?
The HFEA has been a very thoughtful, deliberative body that has provided rational
oversight of sensitive
research areas, and this establishes a strong precedent for allowing this type of
research to go forward,» says George Daley, a stem -
cell biologist at Children's Hospital Boston in Massachusetts.
His contributions to both medical ethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem
cell research, international HIV prevention
research, global health and
research oversight.
Specific activities include optimizing the conduct and
oversight of gene transfer
research, updating and interpreting biosafety policies under the NIH Guidelines Involving Research with Recombinant and Synthetic Nucleic Acids, providing critical input on governmental policies regarding dual use research, the NIH Stem Cell R
research, updating and interpreting biosafety policies under the NIH Guidelines Involving
Research with Recombinant and Synthetic Nucleic Acids, providing critical input on governmental policies regarding dual use research, the NIH Stem Cell R
Research with Recombinant and Synthetic Nucleic Acids, providing critical input on governmental policies regarding dual use
research, the NIH Stem Cell R
research, the NIH Stem
Cell Registry.
The International Society for Stem
Cell Research has responded the recent statement from the FDA regarding stem cell treatments, commending them for their efforts on enforcement and «appropriate oversight» in policy direction for the regulation of stem cell treatments and regenerative medic
Cell Research has responded the recent statement from the FDA regarding stem
cell treatments, commending them for their efforts on enforcement and «appropriate oversight» in policy direction for the regulation of stem cell treatments and regenerative medic
cell treatments, commending them for their efforts on enforcement and «appropriate
oversight» in policy direction for the regulation of stem
cell treatments and regenerative medic
cell treatments and regenerative medicine.